Powering Weakened and Stressed Cells in ALS to Function Better with Nanocrystal Therapy

Rob Etherington, president and CEO of Clene Nanomedicine, discusses the neurodegenerative condition ALS, the role that the compromised ability of cells to produce energy play in the disorder, and why the company believes its gold nanocrystal therapy has the potential to improve function in people with the condition.